Version 2.77

Status Information

Status
TRIAL

Term Description

Blood collection and bioassay for ascertaining levels of Immunoglobulin E. Licensing and guideline requirements for manufacturers and laboratories performing these tests have been set forth by the Food and Drug Administration and the Clinical Laboratory Improvement Amendment of 1988. These measures have assisted in ensuring more consistent results but do not address either accuracy or precision parameters in a comprehensive fashion. In summary, one of the major challenges in the development of consistent allergy testing is the need to identify and accept a well-recognized test standard. An ideal immunoassay for specific IgE antibodies should meet certain analytic performance criteria. These criteria include a slope of unity over the useful measurement range for all allergens, low variation across replicate measurements, statistically determined limits of detection, a practical cut-off point, and defined saturation points. For an assay to be considered as a standard, it would require close approximation to these criteria. There is currently no established standard in this field.
Source: Regenstrief LOINC

Reference Information

Type Source Reference
Article Consensus measures for Phenotypes and Exposures Williams, P. B., Barnes, J. H., Szeinbach, S. L., & Sullivan, T. J. (2000). Analytic precision and accuracy of commercial immunoassays for specific IgE: establishing a standard. Journal of Allergy and Clinical Immunology, 105(6), 1221-1230.
Article Consensus measures for Phenotypes and Exposures Dolen, WK. (2003). IgE antibody in the serum--detection and diagnostic significance. Allergy, 58(5), 717-723.

Fully-Specified Name

Component
PhenX - respiratory - immunoglobulin E - total and specific protocol 090701
Property
-
Time
Pt
System
^Patient
Scale
-
Method
PhenX

Additional Names

Short Name
Resp immunoglobulin E proto

Survey Question

Source
PX090701

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.66
Change Reason
Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.

Member of these Panels

LOINC Long Common Name
62611-9 PhenX domain - Respiratory

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) PhenX - respiratorio - inmunoglobulina E - protocolo total y específico 090701:-:Punto temporal:^ Paciente:-:PhenX
it-IT Italian (Italy) PhenX - respiratorio - Immunoglobuline E - totali e specifiche, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RU Russian (Russian Federation) PhenX - дыхание - иммуноглобулин Е - общий и специфический протокол:-:ТчкВрм:^Пациент:-:PhenX
Synonyms: Точка во времени;Момент
zh-CN Chinese (China) PhenX - 呼吸系统 - 免疫球蛋白 E - 总计与特异性方案 090701:-:时间点:^患者:-:PhenX
Synonyms: Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 E 型 Ig PhenX - 呼吸系统 - 免疫球蛋白 E（IgE） - 总计与特异性方案 090701;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 丙种球蛋白 免疫球蛋白（Immunoglobulin，Ig） 免疫球蛋白类 全体数量 全部 共计 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 总 总和 总数 总量 总额 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 汇总 特异 特异性的 特异的 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62621-8